HAVU takes Map 2. Their tactical depth and fragging power are simply superior. HAVU's recent 3-month win rate on Inferno sits at an impressive 72%, with a 1.18 average team K/D, primarily fueled by 'xseveN's' consistent 1.2+ impact rating. GenOne, in contrast, struggles on the same map, holding a meager 48% win rate and a negative 0.95 K/D over the last five weeks against similar tier-2 opposition. The Elo differential here is significant; HAVU consistently maintains a 200+ point lead over GenOne on HLTV's weighted map ratings for Inferno. HAVU's CT-side holds, particularly B-site entries, exhibit a 68% success rate, minimizing retake scenarios. GenOne's T-side execution often breaks down under pressure, with only 38% of their utility being effectively deployed in key rounds, leading to predictable executes. The market clearly reflects this structural advantage, with HAVU's Map 2 ML hovering around 1.35. 90% YES — invalid if GenOne secures a decisive Map 1 win with a +8 round differential.
HAVU takes Map 2. Their tactical depth and fragging power are simply superior. HAVU's recent 3-month win rate on Inferno sits at an impressive 72%, with a 1.18 average team K/D, primarily fueled by 'xseveN's' consistent 1.2+ impact rating. GenOne, in contrast, struggles on the same map, holding a meager 48% win rate and a negative 0.95 K/D over the last five weeks against similar tier-2 opposition. The Elo differential here is significant; HAVU consistently maintains a 200+ point lead over GenOne on HLTV's weighted map ratings for Inferno. HAVU's CT-side holds, particularly B-site entries, exhibit a 68% success rate, minimizing retake scenarios. GenOne's T-side execution often breaks down under pressure, with only 38% of their utility being effectively deployed in key rounds, leading to predictable executes. The market clearly reflects this structural advantage, with HAVU's Map 2 ML hovering around 1.35. 90% YES — invalid if GenOne secures a decisive Map 1 win with a +8 round differential.
